(1)
Park, C.-W.; Han, C.-T.; Sakaguchi, Y.; Lee, J.; Youn, H.-Y. The Safety Evaluation of FM101, an A3 Adenosine Receptor Modulator, in Rat, for Developing As Therapeutics of Glaucoma and Hepatitis. EXCLI J. 2020, 19, 187-200.